Department of Orthopaedics, Tianjin Medical University General Hospital, No.154 Anshan Road, Heping District, Tianjin 300052, PR China; Tianjin Neurological Institute, Key Laboratory of Post-Neuroinjury Neuro-repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, No. 154 Anshan Road, Heping District, Tianjin 300052, PR China.
Department of Orthopedics, Henan Provincial People's Hospital, Zhengzhou, China.
Am J Emerg Med. 2018 Jul;36(7):1280-1286. doi: 10.1016/j.ajem.2018.04.010. Epub 2018 Apr 5.
The application of atropine for pediatric sedation in the emergency department remains controversial. Our objective was to perform a comprehensive review of the literature and assess the clinical indexes in groups with and without atropine use.
PubMed, EMBASE, and the Cochrane Library were searched for randomized and non-randomized studies that compared ketamine and ketamine plus atropine for pediatric sedation. The risk ratio with 95% confidence interval was calculated using either a fixed- or random-effects model according to the value of I.
One retrospective study and four randomized controlled trials were identified to compare the clinical indexes. For the clinical indexes, the ketamine plus atropine group had better outcomes than the ketamine group in hypersalivation (P<0.05), but indexes of rash and tachycardia were worse. The two methods of sedation were comparable for nausea, vomiting, desaturation, agitation and laryngospasm (P>0.05).
Based on the current evidence, the group receiving atropine had reduced hypersalivation and increased rash and tachycardia; no differences were observed in nausea, vomiting, desaturation, agitation and laryngospasm between the two groups. Given that some of the studies were of low quality, additional high-quality randomized controlled trials should be conducted to further verify these findings.
在急诊科中,阿托品在儿科镇静中的应用仍存在争议。我们的目的是对文献进行全面回顾,并评估使用和不使用阿托品的组中的临床指标。
检索了 PubMed、EMBASE 和 Cochrane 图书馆中比较氯胺酮和氯胺酮加阿托品用于儿科镇静的随机和非随机研究。根据 I 值,使用固定效应或随机效应模型计算风险比及其 95%置信区间。
确定了一项回顾性研究和四项随机对照试验来比较临床指标。对于临床指标,加用阿托品的氯胺酮组在流涎(P<0.05)方面的结果优于氯胺酮组,但皮疹和心动过速的指标较差。两种镇静方法在恶心、呕吐、饱和度降低、激越和喉痉挛方面无差异(P>0.05)。
根据现有证据,接受阿托品的组唾液分泌减少,皮疹和心动过速增加;两组之间在恶心、呕吐、饱和度降低、激越和喉痉挛方面没有差异。由于一些研究质量较低,应该进行更多高质量的随机对照试验来进一步验证这些发现。